Mr. Lobo joins Stryker after nearly a decade at Johnson & Johnson, where he held a number of senior-level leadership roles, most recently as worldwide president of Ethicon Endo-Surgery. These moves follow Stryker’s recent closing of the acquisition of Boston Scientific’s neurovascular division. The new group includes Stryker’s neurovascular and spine divisions.
Read the company news release about Mr. Kevin Lobo’s appointment at Stryker.
Related Articles on Device Company Executive Moves:
Klaus Radermacher Joins ConforMIS Scientific Advisory Board
NuOrtho Surgical Appoints Greg Rainey to Board of Directors
Wright Medical Group’s Chief Technology Officer Fired Amid Leadership Shuffle
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
